GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity

Coverage, in order

1. 6d ago
   
   MedPage Today indie observational

   GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity

   (MedPage Today) -- Diabetic patients treated with GLP-1 receptor agonists had a lower cancer risk versus insulin and sulfonylureas but not other diabetes medications, although the benefits varied by diabetes severity, a large cohort analysis with...

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.